'Won't Do Anything Special': Dr Reddy's Stands Pat After Trump's 200% Tariff Threat

Dr Reddy's CEO said proposed US tariffs on generic medicines will raise drug prices for American consumers, while ruling out any immediate shift in manufacturing.